Home ProMIS Neurosciences

ProMIS Neurosciences

In operation
Post-IPO Round
Biotechnology R&D Developer
Basic
Enterprise Profile

Basic Information

ProMIS Neurosciences is a development-stage biotechnology company focused on discovering and developing selective therapeutic antibodies targeting toxic oligomers associated with the development and progression of neurodegenerative diseases.
ProMIS Neurosciences, Inc.
Toronto,Ontario,Canada
15~50 people
January 01, 2004
info@amorfix.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
# Nervous System Diseases
Application Scenarios
Innovative Drugs